Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update.

Neurology

From Department of Neurology (J.M.H.-M.), Emory University Brain Health Center, Atlanta, GA; SOC Telemed (J.M.H.-M., T.M.B.), Reston, VA; Department of Neurology (J.L.A.), University of Rochester Medical Center, NY; Intensive Neuro (E.R.A.), Gulfport, FL; Sandler Neurosciences Center (R.B.), University of California, San Francisco; iNeuro Headache Specialist (M.C.), McLean, VA; American Academy of Neurology (M.D.O., S.R.W.), Minneapolis, MN; UCLA Seizure Disorder Center (D.S.E.) and Reed Neurological Research Center (B.S.G.), University of California, Los Angeles; Department of Neurology (D.E.-L.), Oregon Health and Science University, Portland; Department of Neurology (L.R.M.), Massachusetts General Hospital, Boston; Department of Neurology (P.N.), Beth Israel Deaconess Medical Center, Boston, MA; Rush Epilepsy Center (M.A.R.) and Department of Neurological Sciences (M.S.), Rush University Medical Center, Chicago, IL; Department of Neurology (N.T.), Johns Hopkins School of Medicine, Baltimore, MD; Department of Neurology (J.W.T.), University of Tennessee Health Science Center, Memphis; Department of Neurology and Neurotherapeutics (B.B.V.), University of Texas Southwestern Medical Center, Dallas; Department of Neurology (S.A.V.), Virginia Commonwealth University, Richmond; American Heart Association/American College of Cardiology (H.P.), National Center, Dallas, TX; and Department of Neurology (R.G.), University of Missouri, Columbia.

Published: January 2020

Purpose: While there is strong evidence supporting the importance of telemedicine in stroke, its role in other areas of neurology is not as clear. The goal of this review is to provide an overview of evidence-based data on the role of teleneurology in the care of patients with neurologic disorders other than stroke.

Recent Findings: Studies across multiple specialties report noninferiority of evaluations by telemedicine compared with traditional, in-person evaluations in terms of patient and caregiver satisfaction. Evidence reports benefits in expediting care, increasing access, reducing cost, and improving diagnostic accuracy and health outcomes. However, many studies are limited, and gaps in knowledge remain.

Summary: Telemedicine use is expanding across the vast array of neurologic disorders. More studies are needed to validate and support its use.

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000008708DOI Listing

Publication Analysis

Top Keywords

neurologic disorders
8
telemedicine
5
telemedicine neurology
4
neurology telemedicine
4
telemedicine work
4
work group
4
group american
4
american academy
4
academy neurology
4
neurology update
4

Similar Publications

A conifer metabolite corrects episodic ataxia type 1 by voltage sensor-mediated ligand activation of Kv1.1.

Proc Natl Acad Sci U S A

January 2025

Bioelectricity Laboratory, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, CA 92697.

Loss-of-function sequence variants in , which encodes the voltage-gated potassium channel Kv1.1, cause Episodic Ataxia Type 1 (EA1) and epilepsy. Due to a paucity of drugs that directly rescue mutant Kv1.

View Article and Find Full Text PDF

Malignant gliomas are heterogeneous tumors, mostly incurable, arising in the central nervous system (CNS) driven by genetic, epigenetic, and metabolic aberrations. Mutations in isocitrate dehydrogenase (IDH1/2) enzymes are predominantly found in low-grade gliomas and secondary high-grade gliomas, with IDH1 mutations being more prevalent. Mutant-IDH1/2 confers a gain-of-function activity that favors the conversion of a-ketoglutarate (α-KG) to the oncometabolite 2-hydroxyglutarate (2-HG), resulting in an aberrant hypermethylation phenotype.

View Article and Find Full Text PDF

Dysregulation of GABAergic inhibition is associated with pathological pain. Consequently, enhancement of GABAergic transmission represents a potential analgesic strategy. However, therapeutic potential of current GABA agonists and modulators is limited by unwanted side effects.

View Article and Find Full Text PDF

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas and the primary cause of mortality in patients with neurofibromatosis type 1 (NF1). These malignancies develop within preexisting benign lesions called plexiform neurofibromas (PNs). PNs are solely driven by biallelic loss eliciting RAS pathway activation, and they respond favorably to MEK inhibitor therapy.

View Article and Find Full Text PDF

Background: Vestibular schwannoma (VS) is a common intracranial tumor that affects patients' quality of life. Reliable imaging techniques for tumor volume assessment are essential for guiding management decisions. The study aimed to compare the ABC/2 method to the gold standard planimetry method for volumetric assessment of VS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!